Live, Interactive Webinars

Cybersight offers free, live online training events for eye health professionals. Expert international faculty discuss comprehensive ophthalmology topics, with live audio and video. Join colleagues from more than 100 countries around the world for interactive presentations, surgical demonstrations and expert Q&A.

A computer, tablet or smartphone with an Internet connection is required to participate. A link to join the session will be sent by email after you register. Can’t make it? Don’t worry, we record every event and post it in the Cybersight Library.

If you attend a Cybersight webinar for at least 80% of the scheduled time, and you have a Cybersight account, you will automatically receive a certificate of attendance 24 hours after the webinar ends.

Schedule of Upcoming Webinars

December 11, 2023
14:00-15:00 GMT/UTC

Myopia in Children Treated for Retinopathy of Prematurity

Dr. Neelam Pawar
Ophthalmologist, Aravind Eye Hospital/University of Michigan, USA

The prevalence of myopia in premature children with or without treatment for ROP is significantly higher than in full-term children. This lecture will explore the dynamics of myopia development in both treated and untreated cases of ROP. This lecture will elaborate on myopia development and evaluate the associated factors in preterm infants treated with anti-VEGF (Intravitreal Bevacizumab) or laser photocoagulation. The latest research findings, clinical insights, and potential strategies to mitigate myopia in the context of ROP will be discussed. (Level: Intermediate)

December 19, 2023
14:00-15:00 GMT/UTC

Low Vision Rehabilitation for Patients with Visual Field Loss

Dr. Micaela Gobeille
Optometrist, New England College of Optometry, USA

Low vision rehabilitation often employs magnification to compensate for reduced visual acuity and central vision loss. However, patients with peripheral visual field loss may have additional functional concerns that are not sufficiently addressed through magnification alone. In this webinar, we will use cases to explore common functional complaints in patients with visual field loss and how these complaints are addressed in low vision management. (Level: Intermediate)

January 8, 2024
14:00-15:00 GMT/UTC

Approach to the Patient With Unexplained Visual Loss

Dr. Karl Golnik
Ophthalmologist, Barrow Neuroscience Institute, USA

Patients will present with visual symptoms and seemingly “normal” eye exams. This webinar will describe an organized, succinct approach to these difficult patients. A variety of neuro-ophthalmic conditions will be discussed in addition to non-organic visual loss. (Level: Beginner and Intermediate)

January 16, 2024
14:00-15:00 GMT/UTC

Everything You Wanted to Know About Goniotomy, but Were Afraid to Ask

Dr. Alex Levin
Ophthalmologist, Flaum Eye Institute, Golisano Children's Hospital and University of Rochester Medical Center, USA

During this live webinar, we will discuss all aspects of goniotomy from case selection, to informed consent, to set-up, to post-op, and beyond. We will also examine various alternatives. Videos will be incorporated into this session with ample time for questions. (Level: All)

January 25, 2024
14:00-15:00 GMT/UTC

Malignant Orbital Tumors of Childhood

Dr. Thomas Johnson
Ophthalmologist, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, USA

During this live webinar, we will discuss the evaluation, diagnosis, and management of malignant orbital tumors in childhood. Rhabdomyosarcoma, metastatic neuroblastoma, secondary retinoblastoma, and others will be discussed. Physicians will learn to recognize clinical signs, perform a focused evaluation, and become familiar with managing these cancers. (Level: Beginner to Intermediate)

February 8, 2024
14:00-15:00 GMT/UTC

Ocular Surface Reconstruction for Severe Ocular Surface Disease

Dr. Marjan Farid
Ophthalmologist, University of California - Irvine, USA

During this live webinar, we will discuss the stages of severe ocular surface disease and limbal stem cell deficiency. We will review overlooked causes of limbal stem cell deficiency and management strategies. We will also examine limbal stem cell transplantation and ocular surface reconstruction, surgical techniques, donor selection, and immunosuppression protocols. (Level: Advanced)

February 16, 2024
14:00-15:00 GMT/UTC

Vitrectomy: It’s (Mostly) About the View

Dr. Omar Shakir
Ophthalmologist, Coastal Eye and Coastal Eye Surgery Center, USA

During this live webinar, I will give an overview of the non-contact and contact visualization options during vitrectomy surgery. We will discuss reusable versus single-use, wide-angle view versus detailed macular work, and contact versus non-contact lens systems. Videos and real intraoperative photos will be used to demonstrate these options. I will leave ample time for questions. (Level: Beginner to Intermediate)

March 1, 2024
14:00-15:00 GMT/UTC

Turning In and Turning Out: Management of Entropion and Ectropion

Dr. Tamara Fountain
Ophthalmologist, Rush University Medical Center, USA

During this live webinar, we will discuss the management of entropion and ectropion. At the conclusion of this lecture, attendees should be able to: (1) identify the anatomic factors that cause both entropion and ectropion, (2) understand the clinical features caused by entropion and ectropion, and (3) select the most appropriate surgical treatment for entropion or ectropion based on the clinical situation. (Level: Beginner)

April 30, 2024
13:00-14:00 GMT/UTC

Gene Therapy for AMD: Are We There Yet?

Dr. Glenn Yiu
Ophthalmologist, University of California, Davis, USA

During this live webinar, we will discuss the concept of retinal gene therapy and its use for rare and common diseases, and how the type of vector, viral dose, and mode of delivery dictate efficacy and safety in both preclinical and clinical studies. We will also discuss ocular immune privilege, the impact of biological barriers, and factors that determine the degree of ocular inflammation related to gene therapy - also known as gene therapy-associated uveitis (GTAU). Finally, we will review gene therapy programs in development for age-related macular degeneration (AMD), as well as early studies using CRISPR-based gene editing technology as potential treatments for AMD. (Level: Beginner and Intermediate)

June 14, 2024
13:00-14:00 GMT/UTC

The Clinical & Surgical Considerations of Gene Therapy in Retina Patients

Dr. Christina Y. Weng
Ophthalmologist, Baylor College of Medicine, USA

During this live webinar, we will discuss the current state of gene therapy for retinal diseases. The indications, mechanism of action, and delivery routes for this novel class of therapeutics will be briefly reviewed. The latest efficacy and safety data of leading gene therapy candidates will be presented along with areas of continued exploration. The participant will leave the webinar with an improved understanding of retinal gene therapy and its potential applications. (Level: Intermediate)